Results 21 to 30 of about 922,637 (337)

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.

open access: yesThe Lancet Diabetes and Endocrinology, 2019
BACKGROUND The DiRECT trial assessed remission of type 2 diabetes during a primary care-led weight-management programme. At 1 year, 68 (46%) of 149 intervention participants were in remission and 36 (24%) had achieved at least 15 kg weight loss.
M. Lean   +23 more
semanticscholar   +1 more source

The role of stereotactic radiosurgery in the multimodal management of growth hormone–secreting pituitary adenomas [PDF]

open access: yes, 2010
Growth hormone (GH)–secreting pituitary adenomas represent a common source of GH excess in patients with acromegaly. Whereas surgical extirpation of the culprit lesion is considered first-line treatment, as many as 19% of patients develop recurrent ...
Liu, Charles Y.   +2 more
core   +1 more source

Pasireotide Long‐Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism

open access: yesJournal of Veterinary Internal Medicine, 2017
Background Long‐term medical management of hypersomatotropism (HS) in cats has proved unrewarding. Pasireotide, a novel somatostatin analogue, decreases serum insulin‐like growth factor 1 (IGF‐1) and improves insulin sensitivity in cats with HS when ...
R. Gostelow   +7 more
doaj   +1 more source

Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.

open access: yesGastroenterology, 2019
BACKGROUND & AIMS Exclusive enteral nutrition (EEN) is recommended for children with mild-to-moderate Crohn's disease (CD) but implementation is challenging.
A. Levine   +17 more
semanticscholar   +1 more source

Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center

open access: yesFrontiers in Endocrinology, 2022
BackgroundThyrotropin (TSH)-secreting pituitary adenomas (TSHomas) account for an extremely rare group of pituitary adenomas. Few studies examined the sensitivity and efficacy of presurgical somatostatin analogs (SSAs) and described the long-term ...
Jie Liu   +12 more
doaj   +1 more source

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND Although induction chemotherapy results in remission in many older patients with acute myeloid leukemia (AML), relapse is common and overall survival is poor. METHODS We conducted a phase 3, randomized, double-blind, placebo-controlled trial
A. Wei   +28 more
semanticscholar   +1 more source

Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

open access: yesGut and Liver, 2016
Background/AimsWe investigated the effectiveness of Helicobacter pylori eradication therapy for gastric mucosa-associated lymphoid tissue (MALT) lymphoma regardless of the H.
Eun Jeong Gong   +12 more
doaj   +1 more source

Detection of monosomy 7 in interphase cells of patients with myeloid disorders [PDF]

open access: yes, 1990
Six patients, five with acute myeloid leukemia (AML) and one with a myelodysplastic syndrome (MDS), were found to have monosomy 7 by conventional cytogenetics at diagnosis.
Cremer, Thomas   +5 more
core   +1 more source

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial

open access: yesJournal of the American Medical Association (JAMA), 2019
Importance High-intensity, aerobically prepared fecal microbiota transplantation (FMT) has demonstrated efficacy in treating active ulcerative colitis (UC).
S. Costello   +16 more
semanticscholar   +1 more source

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study

open access: yesMicrobiome, 2020
The role of the gut microbiota in Crohn’s disease (CD) is established and fecal microbiota transplantation (FMT) is an attractive therapeutic strategy. No randomized controlled clinical trial results are available. We performed a randomized, single-blind,
Harry Sokol   +45 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy